Table 1.
Demographic and baseline characteristics of study groups
| Characteristics | Selenium (n = 29) | Control (n = 25) | P value |
|---|---|---|---|
| Age | 35 (17–82) | 41 (19–82) | 0.18a |
| Male/femaleb | 24/5 | 22/3 | 0.59 |
| APACHE IIb | 17 ± 4.3 | 16.4 ± 4.0 | 0.71 |
| SOFAb | 8 ± 2.7 | 8.3 ± 3 | 0.69 |
| PaO2/FiOb2 | 160 ± 89 | 150 ± 75 | 0.65 |
| Sepsis, n (%) | 7 (24.1) | 6 (24) | 0.90 |
| Severe sepsis, n (%) | 8 (27.6) | 7 (28) | 0.89 |
| Septic shock, n (%) | 14 (48.3) | 12 (48) | 0.86 |
| Pneumonia, n (%) | 18 (63) | 19 (76) | 0.7 |
| Peritonitis, n (%) | 7 (24) | 3 (12) | 0.20 |
| SSTI infection, n (%) | 3 (10) | 2 (8) | 0.67 |
| CNS infection, n (%) | 0 (0) | 1 (4) | 0.33 |
| CR infection, n (%) | 1 (3) | 0 (0) | 0.32 |
| Gram positive, n (%) | 4 (13.7) | 1 (4) | 0.20 |
| Gram negative, n (%) | 8 (27.6) | 9 (36) | 0.9 |
| No growth, n (%) | 17 (58.7) | 15 (60) | 0.87 |
APACHE II acute physiological and chronic health evaluation II, SOFA sequential organ failure assessment, SSTI skin and soft tissue, CNS central nervous system, CR catheter line related
aData given as media (IQR)
bData given as mean ± SD